INS and diabetes mellitus: A large study based on the Swedish National Diabetes Register involving more than 51,000 Type 2 DM patients reported similar observation, with users of metformin-containing therapies having shortest duration of diabetes and higher mean BMI (30 to 32 kg/m2) than users of other oral glucose-lowering drugs or insulin (27 to 28 kg/m2) [29].